“Breast Cancer Patients Can Safely Interrupt Endocrine Therapy to Attempt Pregnancy, Study Finds”
The POSITIVE trial findings, published in The New England Journal of Medicine, offer strong evidence that young patients with breast cancer can safely interrupt adjuvant endocrine therapy to attempt pregnancy without increasing their risk of breast cancer recurrence or new contralateral breast cancer. Before the trial, the risks associated with taking a break from endocrine … Read more